secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bellerophon Therapeutics, Inc. (—)
CIK:        0001600132
Form:       8-K
Filed at:   2024-01-30T23:59:59+00:00
Accession:  0001104659-24-007999
Event type: other_material
Sentiment:  negative
Materiality: 0.90
Item codes: 1.01, 5.03, 3.02, 3.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bellerophon issues special voting preferred stock, reschedules special meeting to approve dissolution
--------------------------------------------------------------------------------

- Issued one share of Series A Preferred Stock for $1.00 with votes equal to outstanding common stock, but only on dissolution proposals.
- Special meeting rescheduled to March 1, 2024 to vote on dissolution; new record date February 5, 2024.
- Subscription agreement acknowledges limited cash and substantial doubt about going concern; company expects to dissolve.
- Series A Preferred is non-convertible, pays no dividends, and is redeemable at any time for $0.01.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1600132/000110465924007999/0001104659-24-007999-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1600132/000110465924007999/tm244367d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-007999

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer